Epitranscriptomics

Show results for

Unknown (175)
Genomics (76)
Transcriptomics (30)
Other (18)
Proteomics (15)
Methylation profiling (3)
Metabolomics (1)

Organisms

Mus musculus (21)
Homo sapiens (17)
Bombyx mori (15)
Onchocerca volvulus (15)
Klebsiella pneumoniae (15)
Musca domestica (15)
Brugia malayi (15)
Schizosaccharomyces pombe (15)
Streptomyces coelicolor A3(2) (15)
Sus scrofa (15)
Human immunodeficiency virus 1 (15)
Oryza sativa Indica Group (15)
Sinorhizobium meliloti BL225C (15)
Rattus norvegicus (5)
synthetic construct (4)
Pinus pinaster (2)
Toxoplasma gondii (2)
Saccharomyces cerevisiae SK1 (1)
Pyrodictium abyssi (1)
Methanosarcina mazei (1)
Methanobrevibacter smithii (1)
Methanomassiliicoccus luminyensis (1)
Methanosphaera stadtmanae (1)
Methanococcus maripaludis (1)
Pyrococcus furiosus (1)
Thermococcus kodakarensis (1)
Haloferax volcanii (1)
Human immunodeficiency virus 1 (1)
Drosophila melanogaster (1)
Danio rerio (1)

Organisms

Mus musculus (26)
Homo sapiens (17)
Rattus norvegicus (4)
synthetic construct (3)
Pinus pinaster (2)
Toxoplasma gondii (2)
Saccharomyces cerevisiae (2)
Candida albicans SC5314 (1)
Saccharomyces cerevisiae SK1 (1)
Sindbis virus (1)
Human immunodeficiency virus 1 (1)
Drosophila melanogaster (1)
Caenorhabditis elegans (1)
Danio rerio (1)

Repository

ENA (75)
geo (52)
pride (15)
MetaboLights (1)

Tissue

Cell culture (3)
Breast adenocarcinoma cell line (1)
Hematopoietic stem cell (1)
Tear (1)
Embryonic stem cell (1)
Bone marrow (1)
Whole body (1)
Epithelial cell (1)

Disease

Breast adenocarcinoma (1)

Technology Type

Mass Spectrometry (15)
Shotgun proteomics (6)
Bottom-up proteomics (3)
SRM/MRM (2)
Top-down proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Mass spectrometry (1)
RNA mass spectrometry (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)

CHEBI ID

CHEBI:178090 (1)
CHEBI:229468 (1)
CHEBI:229469 (1)
CHEBI:20129 (1)
CHEBI:19229 (1)
CHEBI:70989 (1)
CHEBI:19228 (1)
CHEBI:20794 (1)
CHEBI:19227 (1)
CHEBI:19062 (1)
CHEBI:69426 (1)
CHEBI:20607 (1)
CHEBI:17802 (1)
CHEBI:17562 (1)
CHEBI:16750 (1)
CHEBI:19065 (1)
CHEBI:21891 (1)
CHEBI:16335 (1)
CHEBI:16704 (1)
CHEBI:16020 (1)
CHEBI:17596 (1)

Metabolite Name

N6-,O2'dimethyladenosine (1)
N4-Methylcytidine (1)
2'-O-methyluridine (1)
6-hydroxymethyladenosine (1)
7-methylguanosine (1)
3-methylcytidine (1)
5-methylcytidine (1)
2'-O-methylguanosine (1)
2'-O-methylcytidine (1)
Uridine (1)
Pseudouridine (1)
Inosine (1)
Guanosine (1)
Cytidine (1)
Adenosine (1)
1-methylinosine (1)
1-methyladenosine (1)
N6-methyladenosine (1)
2'-O-methyladenosine (1)
N4-Acetylcytidine (1)
1-methylguanosine (1)

First Public Date

2025 (19)
2022 (10)
2021 (10)
2017 (9)
2026 (7)
2020 (6)
2024 (5)
2023 (5)
2019 (3)
2016 (1)

Classification

viruses (2)
protozoa (2)
fungi (1)

Release Date

2021 (31)
2025 (28)
2023 (26)
2022 (20)
2024 (19)
2020 (18)
2019 (8)
2018 (8)
2026 (6)
2017 (6)
2015 (2)
2016 (1)

Lab affiliation

STORM Therapeutics Limited Cambridge United Kingdom (3)
STORM Therapeutics Limited, Cambridge, United Kingdom (3)
Guangzhou National Laboratory, Guangzhou 510005, China (1)
Associate Professor Department of Chemistry and Biochemistry 126 Integrated Sciences Building Kent State University (1)
Biological Engineering, CEHS, MIT (1)
Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM, Montpellier, France (1)
Helmholtz Centre for Infection Research Dept. of Molecular Bacteriology Inhoffenstr. 7 D-38124 Braunschweig Germany (1)
Head of Laboratory of Epitranscriptomics Faculty of Biology, Biological and Chemical Research Centre, University of Warsaw, Poland (1)
Chinese Academy of Agricultural Science (1)
Underwood-Prescott Professor, Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 56-731 Cambridge, MA 02139-4307 (1)
Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, California 92521, United States (1)

Publication date

2025 (18)
2017 (9)
2020 (8)
2026 (7)
2022 (7)
2024 (5)
2021 (5)
2019 (4)
2023 (2)
2018 (2)
2016 (1)

Previous page
1 / 32
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 32
Next page

Sort by:

Relevance

Page size

The mechanism of cardiotoxicity induced by piperlopicin and bufalin was revealed by epitranscriptomics

PRJNA1131336 | ENA

Epitranscriptomics in Normal and Malignant Hematopoiesis.

Not available

S-EPMC7555315 | biostudies-literature

The mechanism of cardiotoxicity induced by evodiamine and matrine was revealed by epitranscriptomics

PRJNA1147763 | ENA

Epitranscriptomics of cardiovascular diseases (Review).

Not available

S-EPMC8651226 | biostudies-literature

The mechanism of cardiotoxicity induced by evodiamine and matrine was revealed by epitranscriptomics

By using epitranscriptomics, the mechanism of cardiotoxicity induced by evodiamine and matrine was discovered. Experimental findings indicated that evodiamine and matrine altered m6A levels within the cells.

ORGANISM(S): Homo sapiens

2024-08-20 | GSE274753 | GEO

The mechanism of cardiotoxicity induced by piperlopicin and bufalin was revealed by epitranscriptomics

By using epitranscriptomics, the mechanism of cardiotoxicity induced by piperlopicin and bufalin was discovered and confirmed through fluorescence imaging, RT-qPCR, and Western blotting. Experimental findings indicated that piperlopicin and bufalin altered m6A levels within the cells.

ORGANISM(S): Rattus norvegicus

2026-07-31 | GSE271405 | GEO

3' RNA Uridylation in Epitranscriptomics, Gene Regulation, and Disease.

Not available

S-EPMC6053540 | biostudies-literature

Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation.

Not available

S-EPMC11770222 | biostudies-literature

Multivariate Analysis of RNA Chemistry Marks Uncovers Epitranscriptomics-Based Biomarker Signature for Adult Diffuse Glioma Diagnostics.

Not available

S-EPMC9453740 | biostudies-literature

Epitranscriptomics m6A analyses reveal distinct m6A marks in tumor necrosis a (TNF-a)-treated HeLa cells